Gossamer Bio Inc reports results for the quarter ended in December - Earnings Summary

Gossamer Bio

17/03/2023 11:47

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 59 cents​​ per share for the quarter ended in December. The
mean expectation of thirteen analysts for the quarter was for a
loss of 62 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 59
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Gossamer Bio Inc shares had fallen by 51.6% this quarter.
    * The company reported a quarterly loss of $55.76 million.
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 17 at 11:47 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.62          -0.59          Beat
 Sep. 30 2022      -0.64          -0.65          Missed
 Jun. 30 2022      -0.70          -0.74          Missed
 Mar. 31 2022      -0.77          -0.76          Beat